🇺🇸 FDA
Patent

US 9115205

Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression

granted A61KA61K2039/55566A61K39/015

Quick answer

US patent 9115205 (Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/55566, A61K39/015